Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway

被引:212
作者
Prouillet, C
Mazière, JC
Mazière, C
Wattel, A
Brazier, M
Kamel, S [1 ]
机构
[1] Univ Picardie, Fac Pharm, UPRES EA 2086,Lab Biol & Pharm Clin, Unite Rech Mecanismes Resorpt Osseuse, F-80038 Amiens 01, France
[2] CHRU Amiens, Hop Nord, Biochim Lab, F-80054 Amiens 01, France
关键词
osteoblasts; alkaline phosphatase; ERK; flavonols; estrogen receptors;
D O I
10.1016/j.bcp.2003.11.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many plant-derived substances have estrogenic activities. Due to their ability to bind the estrogen receptor (ER), these compounds have the potential to counteract the deleterious effects of estrogen deficiency on bone. In this study, we investigated the in vitro effect of two widespread flavonols, quercetin and kaempferol, on alkaline phosphatase (ALP) activity in MG-63 cultured human osteoblasts. We found that both flavonols significantly increased ALP activity. This effect was markedly reduced by PD 98059, an inhibitor of the extracellular regulated kinase (ERK) pathway, and by ICI 182780, an antagonist of ERs. Western blot studies confirmed that ERK is rapidly activated in cells treated by both flavonols. Finally, ICI 182780 markedly inhibits the flavonol-induced ERK activation. The data presented in this study support the conclusion that, in MG-63 osteoblasts (i) the increase in ALP activity by flavonols involves a rapid stimulation of ERK activation but also involves the ER, and that (ii) the activation of ERK by flavonols occurs most likely downstream of the ERs activation. Taken together, these results suggest that flavonols derivatives as quercetin and kaempferol can stimulate osteoblastic activity. Such compounds may represent new pharmacological tools for the treatment of osteoporosis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1307 / 1313
页数:7
相关论文
共 35 条
[1]   Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis [J].
Arjmandi, BH ;
Alekel, L ;
Hollis, BW ;
Amin, D ;
StacewiczSapuntzakis, M ;
Guo, P ;
Kukreja, SC .
JOURNAL OF NUTRITION, 1996, 126 (01) :161-167
[2]   Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content [J].
Arjmandi, BH ;
Birnbaum, R ;
Goyal, NV ;
Getlinger, MJ ;
Juma, S ;
Alekel, L ;
Hasler, CM ;
Drum, ML ;
Hollis, BW ;
Kukreja, SC .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06) :1364S-1368S
[3]   Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells [J].
Arts, J ;
Kuiper, GGJM ;
Janssen, JMMF ;
Gustafsson, JA ;
Lowik, CWGM ;
Pols, HAP ;
VanLeeuwen, JPTM .
ENDOCRINOLOGY, 1997, 138 (11) :5067-5070
[4]  
Brubaker KD, 2000, J CELL BIOCHEM, V76, P206
[5]  
Christiansen C, 1990, Osteoporos Int, V1, P7
[6]   Intracellular signaling pathways: Nongenomic actions of estrogens and ligand-independent activation of estrogen receptors [J].
Coleman, KM ;
Smith, CL .
FRONTIERS IN BIOSCIENCE, 2001, 6 :D1379-D1391
[7]   PATHOGENESIS OF OSTEOPOROSIS [J].
DEMPSTER, DW ;
LINDSAY, R .
LANCET, 1993, 341 (8848) :797-801
[8]   RAPID COLORIMETRIC ASSAY FOR CELL-GROWTH AND SURVIVAL - MODIFICATIONS TO THE TETRAZOLIUM DYE PROCEDURE GIVING IMPROVED SENSITIVITY AND RELIABILITY [J].
DENIZOT, F ;
LANG, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 89 (02) :271-277
[9]   Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1 [J].
Duan, RQ ;
Xie, W ;
Burghardt, RC ;
Safe, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :11590-11598
[10]   Rapid activation of MAP kinase by estrogen in the bone cell line [J].
Endoh, H ;
Sasaki, H ;
Maruyama, K ;
Takeyama, K ;
Waga, I ;
Shimizu, T ;
Kato, S ;
Kawashima, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (01) :99-102